Rory B.  Riggs net worth and biography

Rory Riggs Biography and Net Worth

Director of Royalty Pharma
Mr. Riggs co-founded Royalty Pharma in 1996 and assumed the role of chairman in 2003. Mr. Riggs is the founder & CEO of Syntax & Locus Analytics. Previously, Mr. Riggs was President of Biomatrix. Mr. Riggs serves or has served on several boards including Fibrogen, Cibus, Sugen, Intra-cellular Therapies and Biomatrix. Mr. Riggs has a BA from Middlebury College and an MBA from Columbia University.

What is Rory B. Riggs' net worth?

The estimated net worth of Rory B. Riggs is at least $565,987.84 as of January 4th, 2024. Mr. Riggs owns 20,099 shares of Royalty Pharma stock worth more than $565,988 as of April 21st. This net worth approximation does not reflect any other investments that Mr. Riggs may own. Learn More about Rory B. Riggs' net worth.

How do I contact Rory B. Riggs?

The corporate mailing address for Mr. Riggs and other Royalty Pharma executives is 110 E 59th Street, New York NY, 10022. Royalty Pharma can also be reached via phone at 212-883-0200 and via email at [email protected]. Learn More on Rory B. Riggs' contact information.

Has Rory B. Riggs been buying or selling shares of Royalty Pharma?

Rory B. Riggs has not been actively trading shares of Royalty Pharma during the past quarter. Most recently, Rory B. Riggs sold 35,702 shares of the business's stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $27.55, for a transaction totalling $983,590.10. Following the completion of the sale, the director now directly owns 20,099 shares of the company's stock, valued at $553,727.45. Learn More on Rory B. Riggs' trading history.

Who are Royalty Pharma's active insiders?

Royalty Pharma's insider roster includes Terrance Coyne (CFO), Henry Fernandez (Director), William Ford (Director), Mario Giuliani (Director), Pablo Legorreta (CEO), George Lloyd (EVP), James Reddoch (EVP), Rory Riggs (Director), Sanjay Singh (CRO), and Marshall Urist (EVP). Learn More on Royalty Pharma's active insiders.

Are insiders buying or selling shares of Royalty Pharma?

In the last twelve months, Royalty Pharma insiders bought shares 4 times. They purchased a total of 485,388 shares worth more than $15,543,025.16. In the last twelve months, insiders at the biopharmaceutical company sold shares 8 times. They sold a total of 2,250,753 shares worth more than $72,415,950.97. The most recent insider tranaction occured on January, 4th when Director Rory B Riggs sold 35,702 shares worth more than $983,590.10. Insiders at Royalty Pharma own 18.7% of the company. Learn More about insider trades at Royalty Pharma.

Information on this page was last updated on 1/4/2024.

Rory B. Riggs Insider Trading History at Royalty Pharma

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2024Sell35,702$27.55$983,590.1020,099View SEC Filing Icon  
1/2/2024Sell235,200$28.52$6,707,904.00254,899View SEC Filing Icon  
5/22/2023Sell1,750,000$32.82$57,435,000.006,762View SEC Filing Icon  
3/29/2023Sell9,926$36.95$366,765.701,586,786View SEC Filing Icon  
12/12/2022Sell40,010$41.98$1,679,619.8096,712View SEC Filing Icon  
12/9/2022Sell19,990$42.07$840,979.30136,722View SEC Filing Icon  
11/17/2022Sell120,000$42.33$5,079,600.00156,712View SEC Filing Icon  
9/14/2022Sell47,975$42.41$2,034,619.75328,737View SEC Filing Icon  
8/9/2022Sell45,000$43.73$1,967,850.00376,712View SEC Filing Icon  
6/29/2022Sell30,000$42.17$1,265,100.00421,712View SEC Filing Icon  
5/19/2022Sell26,304$40.09$1,054,527.36575,408View SEC Filing Icon  
3/29/2022Sell60,000$38.59$2,315,400.00View SEC Filing Icon  
3/21/2022Sell39,867$39.05$1,556,806.35View SEC Filing Icon  
3/18/2022Sell129,222$39.55$5,110,730.10View SEC Filing Icon  
12/28/2021Sell109,448$40.21$4,400,904.08View SEC Filing Icon  
11/16/2021Sell12,565$42.01$527,855.65View SEC Filing Icon  
9/28/2021Sell40,000$36.75$1,470,000.00View SEC Filing Icon  
6/28/2021Sell167,448$42.11$7,051,235.28679,760View SEC Filing Icon  
6/25/2021Sell666,464$42.72$28,471,342.08679,760View SEC Filing Icon  
10/20/2020Sell463,200$42.00$19,454,400.00463,200View SEC Filing Icon  
See Full Table

Rory B. Riggs Buying and Selling Activity at Royalty Pharma

This chart shows Rory B Riggs's buying and selling at Royalty Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Royalty Pharma Company Overview

Royalty Pharma logo
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Read More

Today's Range

Now: $28.16
Low: $27.69
High: $28.19

50 Day Range

MA: $29.77
Low: $27.46
High: $31.33

2 Week Range

Now: $28.16
Low: $25.92
High: $36.48

Volume

1,775,773 shs

Average Volume

2,230,958 shs

Market Capitalization

$16.82 billion

P/E Ratio

14.90

Dividend Yield

2.98%

Beta

0.45